Erye Biotechnology Co., Ltd.

Announcement on Suspension of Conversion for 'Yirui Convertible Bonds' During 2025 Equity Distribution Period

Legal Opinion from GuoHao Law Firm (Shenzhen) on the 2025 Annual Shareholders' Meeting of Shenzhen Yirui Biotechnology Co., Ltd.

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

On-site Inspection Report of Dongxing Securities Co., Ltd. on Shenzhen Yirui Biotechnology Co., Ltd. for 2025

Summary Report of Continuous Supervision and Sponsorship of Dongxing Securities Co., Ltd. on the Issuance of Convertible Corporate Bonds by Shenzhen Yirui Biotechnology Co., Ltd. to Unspecified Objects

Verification Report of Huaxing Accounting Firm (Special General Partnership) on the Storage and Use of Fund Raised by Shenzhen Yirui Biotechnology Co., Ltd. in 2025

Announcement on the Proposed Reappointment of Accounting Firm for 2026

Continuous Supervision Tracking Report of Dongxing Securities Co., Ltd. on Shenzhen Yirui Biotechnology Co., Ltd. for 2025

2025 Independent Director Work Report (Zhou Wanjun)

2025 Independent Director Work Report (Yuan Ruobin)

2025 Independent Director Work Report (Xiong Ying)

Announcement on the 2025 Online Performance Briefing

Verification Opinion of Dongxing Securities Co., Ltd. on the 2025 Internal Control Self-Assessment Report of Shenzhen Yirui Biotechnology Co., Ltd.

2025 Internal Control Audit Report

2025 Internal Control Self-Assessment Report

Compensation Management System for Directors and Senior Management

Announcement on the Change of Accounting Policies

Announcement on the Provision for Asset Impairment in 2025

Announcement on the Change of Senior Management Personnel

Feasibility Analysis Report on the Foreign Exchange Hedging Business

Announcement on the Company's Foreign Exchange Hedging Business

Notice of the 2025 Annual Shareholders' Meeting

Announcement of the Resolution of the 15th Meeting of the Third Board of Directors

Announcement on the Profit Distribution Plan for 2025

Quarterly Report for the First Quarter of 2026

Special Report on the Storage and Use of Fund Raised in 2025

Special Verification Report of Dongxing Securities Co., Ltd. on the Storage and Use of Fund Raised by Shenzhen Yirui Biotechnology Co., Ltd. in 2025

Special Verification Opinion of Huaxing Accounting Firm (Special General Partnership) on the Revenue Deduction Matters of Shenzhen Yirui Biotechnology Co., Ltd.

Report from the Audit Committee of the Board of Directors on the Evaluation of the Performance of the Accounting Firm for the Year 2025 and the Fulfillment of Supervisory Duties

Special Report from Huaxing Accounting Firm (Special General Partnership) on Non-Operating Fund Occupation and Other Related Fund Transactions of Shenzhen Yirui Biotechnology Co., Ltd.

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025